跳到主要內容

很遺憾,我們無法支援你的瀏覽器。如果可以,請升級到新版本,或使用 Mozilla Firefox、Microsoft Edge、Google Chrome 或 Safari 14 或更新版本。如果無法升級,而且需要支援,請將你的回饋寄給我們。

我們衷心感謝你對這個新體驗的回饋。告訴我們你的想法 打開新的分頁/視窗

Elsevier
與我們共同出版

Committee & Speakers

Conference Chairs

Dorothee Dormann, Johannes Gutenberg University, Mainz, Germany

Fen-Biao Gao, University of Massachusetts, USA

Aaron Gitler, University of Stanford, USA

Speakers

Keynote Victor Ambros, University of Massachusetts Chan Medical School, USA

Session 1: Dysregulated RNA metabolism in neurological diseases Pietro Fratta, University of College London, UK Leslie Thompson, University of California, Irvine, USA

Session 2: Physiological functions of disease-linked RNA-binding proteins Joel Richter, University of Massachusetts Chan Medical School, USA Gene Yeo, University of California, San Diego, USA

Session 3: Biomolecular condensates and their role in normal RNA processing and in disease Simon Alberti, Dresden University of Technology, Germany Roy Parker, University of Colorado, Boulder, USA

Session 4: Human genetics and genomics insights into neurological diseases Don Cleveland, University of California, San Diego, USA Rosa Rademakers, VIB Center for Molecular Neurology, Antwerp, Belgium

Session 5: Structural insights into pathological RNA-binding proteins Magdalini Polymenidou, University of Zürich, Switzerland Ben Ryskeldi-Falcon, MRC Cambridge, UK

Session 6: Toxicity of repeat RNAs and RAN proteins Dieter Edbauer, German Center for Neurodegenerative Diseases, Munich, Germany Laura Ranum, University of Florida, USA

Session 7: Novel biomarkers due to dysregulated RNA metabolism Michael Ward, National Institutes of Health, USA Phil Wong, The John Hopkins University, USA

Session 8: RNA-based therapeutics Anastasia Khvorova, University of Massachusetts Chan Medical School, USA Matthew Simon, Denali Therapeutics, USA